SKILLMAN, N.J. January 21, 2025 – Kenvue Inc. today announced the appointment of Penelope Giraud to the role of President, Skin Health & Beauty for Asia Pacific and Latin America, leading the strategic direction of our iconic portfolio of brands, including Neutrogena®, Aveeno®, and Dr. Ci Labo® in the regions.
“We are very pleased to have Penelope join Kenvue in this critical role,” said Charmaine England, Chief Growth Officer at Kenvue. “She is a seasoned beauty industry professional with deep expertise and an exceptional track record in growing culturally relevant global brands that are loved by consumers and dermatologists. Combined with her deep expertise in modern marketing, we are confident that her leadership will strengthen the growth trajectory of our iconic skincare and beauty brands in these key markets.”
“I am delighted to join Kenvue and have the opportunity to work on this beautiful portfolio of iconic brands,” said Penelope Giraud. “I am excited to get started with the teams on building an impactful strategy to enhance the brands’ footprint and progress growth, while delivering brilliant consumer experiences.”
Penelope is joining Kenvue from L’Oreal, where she has spent the past 23 years focused on skincare and beauty, with strong expertise in dermatological skincare, healthcare professional engagement, marketing, and digital strategies. At L’Oreal, Penelope led the global team responsible for the integration of the CeraVe® brand into the portfolio, defining a profitable and successful business model and best-in-class global digital and healthcare professional strategy that has resulted in the brand’s unprecedented growth. Further, Penelope led the La Roche-Posay® brand in the United States. Under her leadership, the brand became a Top 5 brand in the region and one of the fastest growing brands in skincare. Prior to joining L’Oreal, Penelope spent time at both Danone and Nestle, in marketing roles of increasing responsibility in the food and supplements space.
About Kenvue
Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
Cautions Concerning Forward-Looking Statements
This alert contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the appointment of Penelope Giraud to the role of President, Skin Health & Beauty for Asia Pacific and Latin America at Kenvue. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates. A list and descriptions of these risks, uncertainties and other factors can be found in Kenvue’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.